Consultant Pharmacist License Renewal

Over the past decade, products derived from the leaves of the Kratom (Mitragyna speciosa) tree have gained popularity in the U.S. Kratom products are reported to be used for a range of self-treatment options including pain, mental disorders, mitigation of drug withdrawal symptoms, and mood elevation in general. This course will provide an overview of kratom’s known pharmacology, chemistry, pharmacokinetics, and use patterns.

This activity reflects the new diabetes care guidelines for 2024 included within the American Diabetes Association (ADA) NEW Standards of Care in Diabetes-2024! New guidelines include updates to recommendations around new class of obesity drugs, new screening practices, diabetes technology, the use of teplizumab, and more!

Over the past decade, products derived from the leaves of the Kratom (Mitragyna speciosa) tree have gained popularity in the U.S. Kratom products are reported to be used for a range of self-treatment options including pain, mental disorders, mitigation of drug withdrawal symptoms, and mood elevation in general. This course will provide an overview of kratom’s known pharmacology, chemistry, pharmacokinetics, and use patterns.

This program is designed to prepare pharmacists for the responsibility of counseling and educating patients and caregivers on signs of opioid overdose and naloxone use in order to improve patient access to naloxone. This program will describe the national overdose concerns associated with opioids, review proper administration of the available naloxone formulations, and describe the current naloxone access laws in place. 

Review the treatment and management of various infectious diseases that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed. 

Review the treatment and management of various endocrinology and bone health conditions that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed.

Review the treatment and management of various pulmonary conditions that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed. 

This CPE program will review the treatment and management of various cardiology health conditions that are commonly managed in the ambulatory care setting. Learners will have the opportunity to apply the content learned to develop patient-specific individualized treatment plans in the context of the disease states reviewed.

This program seeks to meet the requirements outlined in the Medication Access and Training Expansion (MATE) Act to provide training on the treatment and management of patients with opioid or other substance abuse disorders.

This CPE program will introduce the participant to the assessment and management of acute pain. This program will be given in two parts. Part 1 will focus on acute non-surgical pain while Part 2 will focus on acute surgical pain and patient controlled analgesia. This program will provide the consultant pharmacist with knowledge and skill in the selection of drug therapy and recommend appropriate efficacy and safety monitoring for both opioid and non-opioid therapies used in the management of both acute non-surgical and surgical pain.   

The goal of this program is to review these conditions and their treatments so as to better understand how they fit into the overall risk picture for metabolic syndrome. Learners will successfully view recorded lecture content available online via an online Learning Management System, complete required readings, and assessment activities for a total of 6.0 hours of CPE.

The course is intended to provide the legal framework for regulation of HDS, what potential quality indicators can be used to make informed recommendations for use, and adequate communication with patients to avoid or reduce the risk of drug interactions with concomitant HDS use.

The purpose of this course is to provide the pharmacist with an overview of motivational interviewing terms and techniques as a communication and counseling approach designed to help patients find their own motivation to make a positive change in their behavior.

This course will update the pharmacist in the prevention and management of infectious diseases and issues that are important to the care of patients in such long-term settings.

The content of this program will provide the pharmacist with a review of thromboembolic risk factors and coagulation disorders. Utilizing current guidelines and recommendations, this program will provide the learner with the tools necessary to provide routine management of anticoagulant therapy in outpatient settings. Key concepts will be reinforced though case applications.

Pharmacists have an important role in providing diabetes management. The content of this program will provide the pharmacist with a review of the pathophysiology of diabetes, oral an injectable diabetes medications and therapeutic plan development. 

During this educational activity, the learner will learn to recognize, treat, and control this chronic condition using patient-centered care.  The learner will have an overview of asthma and will be familiar with patient assessment, the appropriate treatments and correct use of inhalers and devices used in asthma.

This program provides an overview of antibiotic stewardship in hospitals, long-term care and outpatient facilities with the goal of empowering pharmacists to address the growing concern of inappropriate antibiotic use.

This Alzheimer’s disease continuing education course covers pharmacologic and medical therapies, the role of pharmacists in caring for patients with Alzheimer’s, strategies for addressing the effects of the disease, and ways to support families and caregivers.

This course is designed as a resource to help prepare the pharmacist for the responsibility of monitoring and managing anticoagulation therapy patients and clinics. It is also designed to serve as a starting point to help the pharmacist prepare for the Certified Anticoagulation Care Provider (CACP) exam. This program is approved by the Florida Board of Pharmacy for consultant pharmacist recertification credit.

This program is intended for licensed consultant pharmacists seeking continuing education for licensure renewal. This course will provide a review of regulatory requirements and clinical knowledge necessary to practice as a consultant pharmacist in the state of Florida.